Medicine
Ampicillin 125 mg powder for injection
Ampicillin 125 mg powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect the constituted solution from freezing. Store at 20° to 25°C (68° to…
Key facts
- Active ingredient (INN)
- Ampicillin
- Brand
- Sold under the generic name
- Strength
- 125 mg
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials
- Manufacturer
- WG Critical Care2 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Protect the constituted solution from freezing. Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01CA01 Ampicillin
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 March 1971
- Identifiers
- RxCUI 308207, 1721473, 1721474 +2DailyMed set ID b371e1a5-1fef-4df2-8940-c4fc02b9e2f0, 38ec7b7a-9caf-45f2-88a1-0f78f089a1e4, 64a04e8c-8f78-46b3-8f45-56ef225a4f74NDC 0781-9401, 44567-105, 0781-3400Application ANDA061395, ANDA062772
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 tray / 1 injection, powder, for solution in 1 vial | 44567-105-10 | WG Critical Care | 10 May 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 December 1966 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ampicillin
Clinical summary
Ampicillin is a penicillin-class antibacterial indicated in the treatment of infections caused by susceptible strains of the designated organisms in conditions. It is available as powder for injection and capsules for intravenous, intramuscular and oral use. MedsAcross supplies Ampicillin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AmpicillinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ampicillin prescribing information (NorthStar Rx) · U.S. National Library of Medicine, DailyMed
Need Ampicillin 125 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.